CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263407249
- Phone
- (302) 295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- EFFECT Other Notice of Effectiveness
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 15 of 19 · 370 filings